Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 271-278

  Feng, Yingmei ^a   Gordts, Stephanie C ^a   Chen, Feng ^b   Hu, Yanhua ^c   Van Craeyveld, Eline ^a   Jacobs, Frank ^a   Carlier, Vincent ^a   Feng, Yuanbo ^b   Zhang, Zhiyong ^a   Xu, Qingbo ^b   Ni, Yicheng ^b   De Geest, Bart ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Bypass; Endothelial progenitor cell; Endothelium; Inflammation; Lipoproteins

Indexed keywords

APOLIPOPROTEIN E; BETA GALACTOSIDASE; BETA1 INTEGRIN; CD31 ANTIGEN; HIGH DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; POLOXAMER; SCAVENGER RECEPTOR BI;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; C57BL 6 MOUSE; CAROTID ARTERY; CAVA VEIN; CELL ADHESION; CELL MIGRATION; CELL REGENERATION; COLONY FORMING CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT PATENCY; GRAFT RECIPIENT; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; VEIN GRAFT DISEASE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS, CD29; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAROTID ARTERIES; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE TRANSFER TECHNIQUES; GRAFT OCCLUSION, VASCULAR; LIPOPROTEINS, HDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; PHOSPHORYLATION; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; STEM CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR GRAFTING; VASCULAR PATENCY; VENAE CAVAE;

EID: 79151485904     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.024     Document Type: Article

References (33)

1. Campeau L., Enjalbert M., Lesperance J., et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation.A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984, 311:1329-1332.
2. Fitzgibbon G.M., Kafka H.P., Leach A.J., et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5.065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996, 28:616-626.
3. Goldman S., Zadina K., Moritz T., et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a department of veterans affairs cooperative study. J Am Coll Cardiol 2004, 44:2149-2156.
4. Raja S.G., Haider Z., Ahmad M., Zaman H. Saphenous vein grafts: to use or not to use?. Heart Lung Circ 2004, 13:403-409.
5. Dietrich H., Hu Y., Zou Y., et al. Rapid development of vein graft atheroma in apoE-deficient mice. Am J Pathol 2000, 157:659-669.
6. Xu Q., Zhang Z., Davison F., Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in apoE-deficient mice. Circ Res 2003, 93:e76-86.
7. Nofer J.R, Levkau B., Wolinska I., et al. Suppression of endothelial cell apoptosis by high-density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 2001, 276:34480-34485.
8. Seetharam D., Mineo C., Gormley A.K., et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 2006, 98:63-72.
9. Tso C., Martinic G., Fan W.H., et al. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 2006, 26:1144-1149.
10. Feng Y., Van Craeyveld E., Jacobs F., et al. Wild-type apo A-I and apo A-I(milano) gene transfer reduce native and transplant arteriosclerosis to a similar extent. J Mol Med 2009, 87:287-297.
11. Feng Y., van Eck M., Van Craeyveld E., et al. Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 2009, 113:755-764.
12. Feng Y., Jacobs F., Van Craeyveld E., et al. Human apoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008, 28:278-283.
13. Murphy A.J., Chin-Dusting J.P., Sviridov D., Woollard K.J. The anti inflammatory effects of high-density lipoproteins. Curr Med Chem 2009, 16:667-675.
14. Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 1998, 97:916-931.
15. Tatewaki H, Egashira K., Kimura S., et al. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J Vasc Surg 2007, 45:1236-1243.
16. Hu Y., Zou Y., Dietrich H., Wick G., Xu Q. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 1999, 100:861-868.
17. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
18. Zou Y., Dietrich H., Hu Y., et al. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998, 153:1301-1310.
19. Van Linthout S., Lusky M., Collen D., De Geest B. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Gene Ther 2002, 9:1520-1528.
20. Jacobs F., Snoeys J., Feng Y., et al. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer. Gene Ther 2008, 15:594-603.
21. Dimmeler S., Aicher A., Vasa M., et al. Hmg-coa reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/akt pathway. J Clin Invest 2001, 108:391-397.
22. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001, 103:2885-2890.
23. Torsney E., Mayr U., Zou Y., et al. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ Res 2004, 94:1466-1473.
24. Manchio J.V., Gu J., Romar L., et al. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery. Ann Thorac Surg 2005, 79:1991-1998.
25. Ingram D.A., Mead L.E., Moore D.B., et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105:2783-2786.
26. Ali Z.A., Bursill C.A., Hu Y., et al. Gene transfer of a broad spectrum cc-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice. Circulation 2005, 112:I235-I241.
27. Cockerill G.W., Rye K.A., Gamble J.R., Vadas M.A., Barter P.J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995, 15:1987-1994.
28. Murphy A.J., Woollard K.J., Hoang A., et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 2008, 28:2071-2077.
29. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
30. Hirschi K.K, Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008, 28:1584-1595.
31. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005, 39:733-742.
32. Chavakis E., Hain A., Vinci M., et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007, 100:204-212.
33. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.